Home
Conditions
Respiratory Syncytial Virus (RSV)

Clinical trial condition

Respiratory Syncytial Virus (RSV)

Explore clinical trials studying Respiratory Syncytial Virus (RSV). Study availability and eligibility vary by location and protocol.

60 public trials 12 recruiting studies

Refine in advanced search Browse all conditions

Respiratory Syncytial Virus (RSV) trial results

Active, Not Recruiting

A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

NCT06564194

Conditions: Communicable Diseases, Disease Attributes, Infections, +4 more
Locations: Health Awareness Jupiter, Florida, United States

DelRicht - New Orleans New Orleans, Louisiana, United States

Sundance Clinical Research St Louis, Missouri, United States

View Trial Details

Active, Not Recruiting

Systems Biological Analysis of Immune Responses to RSV Vaccine

NCT07185399

Conditions: Respiratory Syncytial Virus (RSV)
Locations: The Hope Clinic of the Emory Vaccine Center Decatur, Georgia, United States

View Trial Details

Active, Not Recruiting

STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus (RSV) in Hospitalised Infants in Australia (STREETON)

NCT07122661

Conditions: Acute Respiratory Illness (ARI), Lower Respiratory Tract Disease, Respiratory Syncytial Virus, +2 more
Locations: Pfizer Sydney, Australia

View Trial Details

Active, Not Recruiting

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)

NCT05913700

Conditions: Acute Disease, Disease Attributes, Pathologic Processes, +3 more
Locations: Rakuwakai Otowa Hospital Kyoto, Japan

Nara City Hospital Nara, Japan

Shimane Prefectural Central Hospital Izumo, Shimane, Japan

View Trial Details

Active, Not Recruiting

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

NCT06216093

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
Locations: Univsersity Hospital Seoul, South Korea

View Trial Details

Active, Not Recruiting

Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above

NCT06642558

Conditions: Respiratory Syncytial Virus (RSV)
Locations: Liangyuan District Center for Disease Prevention and Control Shangqiu, Henan, China

View Trial Details

Active, Not Recruiting

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

NCT04896853

Conditions: COVID-19 Acute Respiratory Distress Syndrome, Influenza A, Metapneumovirus Pneumonia, +1 more
Locations: Department of Cardiology, Respiratory medicine and Physiology, Örebro University Hospital Örebro, Sweden

View Trial Details

Active, Not Recruiting

A Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults

NCT06442241

Conditions: Infections, Mononegavirales Infections, Paramyxoviridae Infections, +6 more
Locations: Nucleus Network Pty Ltd. Melbourne, Australia

View Trial Details

Active, Not Recruiting

Efficacy of LiveSpo Navax in Supportive Treatment of Pneumonia in Children With RSV and Bacterial Co-infections

NCT05929599

Conditions: Acute Respiratory Tract Infections, Infections, Lung Diseases, +4 more
Locations: The Center for Pulmonology and Respiratory Care, Vietnam National Children's Hospital Hà Nội, Vietnam

View Trial Details

Active, Not Recruiting

Understanding RSV: Severe Disease and the Long Term Consequences

NCT03756766

Conditions: Respiratory Syncytial Virus (RSV)
Locations: Oxford University Hospitals NHS Trust Oxford, United Kingdom

Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine Oxford, United Kingdom

View Trial Details

Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) trial results

Related conditions